Clinical Trials Directory

Trials / Completed

CompletedNCT03957031

Gastric Cancer Risk Factors Associated With EU and CELAC Populations

Status
Completed
Phase
Study type
Observational
Enrollment
1,600 (actual)
Sponsor
Fundación para la Investigación del Hospital Clínico de Valencia · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The study uses a case-control design that examines the differences in types of exposures between cases defined with a pathological confirmation of GC diagnosis, and controls, defined as patients to whom a gastroscopy was indicated and confirmed absent of GC i

Detailed description

GC is associated to several known risk factors. Epidemiological and molecular features of GCs can vary widely. The reasons behind these differences are multiple and complex and may include genetic susceptibility, strains of the bacterium Helicobacter pylori (H. pylori), Epstein Barr virus infection, dietary factors and others. These factors can influence GC outcomes. There is little knowledge regarding how these risk factors are associated with GC in CELAC and EU populations. The primary objectives of this study are to: 1. Identify risk factors associated with GC in the CELAC and EU populations participating in this study including Argentina, Spain, Mexico, Netherlands, Chile, Portugal and Paraguay. 2. Identify clinical, demographic, and epidemiological differences among the populations participating in this study

Conditions

Timeline

Start date
2019-05-31
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2019-05-21
Last updated
2024-05-09

Locations

8 sites across 7 countries: Argentina, Chile, Mexico, Netherlands, Paraguay, Portugal, Spain

Source: ClinicalTrials.gov record NCT03957031. Inclusion in this directory is not an endorsement.

Gastric Cancer Risk Factors Associated With EU and CELAC Populations (NCT03957031) · Clinical Trials Directory